Lee PP - Search Results

1

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, Roederer M, Lee PP. Rubio V, et al. Among authors: lee pp. Nat Med. 2003 Nov;9(11):1377-82. doi: 10.1038/nm942. Epub 2003 Oct 5. Nat Med. 2003. PMID: 14528297

2

Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses.

Kohrt HE, Shu CT, Stuge TB, Holmes SP, Weber J, Lee PP. Kohrt HE, et al. Among authors: lee pp. J Immunother. 2005 Jul-Aug;28(4):297-305. doi: 10.1097/01.cji.0000162780.96310.e4. J Immunother. 2005. PMID: 16000947

3

Diversity and recognition efficiency of T cell responses to cancer.

Stuge TB, Holmes SP, Saharan S, Tuettenberg A, Roederer M, Weber JS, Lee PP. Stuge TB, et al. Among authors: lee pp. PLoS Med. 2004 Nov;1(2):e28. doi: 10.1371/journal.pmed.0010028. Epub 2004 Nov 30. PLoS Med. 2004. PMID: 15578105 Free PMC article. Clinical Trial.

4

Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.

Chen DS, Soen Y, Stuge TB, Lee PP, Weber JS, Brown PO, Davis MM. Chen DS, et al. Among authors: lee pp. PLoS Med. 2005 Oct;2(10):e265. doi: 10.1371/journal.pmed.0020265. Epub 2005 Sep 20. PLoS Med. 2005. PMID: 16162034 Free PMC article. Clinical Trial.

5

Cytotoxic T lymphocyte responses against melanocytes and melanoma.

Chang GY, Kohrt HE, Stuge TB, Schwartz EJ, Weber JS, Lee PP. Chang GY, et al. Among authors: lee pp. J Transl Med. 2011 Jul 27;9:122. doi: 10.1186/1479-5876-9-122. J Transl Med. 2011. PMID: 21794122 Free PMC article.

6

Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis.

Chung B, Stuge TB, Murad JP, Beilhack G, Andersen E, Armstrong BD, Weber JS, Lee PP. Chung B, et al. Among authors: lee pp. Cell Rep. 2014 Aug 7;8(3):871-882. doi: 10.1016/j.celrep.2014.06.052. Epub 2014 Jul 31. Cell Rep. 2014. PMID: 25088413 Free PMC article.

7

Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

Critchley-Thorne RJ, Yan N, Nacu S, Weber J, Holmes SP, Lee PP. Critchley-Thorne RJ, et al. Among authors: lee pp. PLoS Med. 2007 May;4(5):e176. doi: 10.1371/journal.pmed.0040176. PLoS Med. 2007. PMID: 17488182 Free PMC article.

8

Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma.

Weber J, Sondak VK, Scotland R, Phillip R, Wang F, Rubio V, Stuge TB, Groshen SG, Gee C, Jeffery GG, Sian S, Lee PP. Weber J, et al. Among authors: lee pp. Cancer. 2003 Jan 1;97(1):186-200. doi: 10.1002/cncr.11045. Cancer. 2003. PMID: 12491520 Free article. Clinical Trial.

9

Rational design of combination enzyme therapy for celiac sprue.

Siegel M, Bethune MT, Gass J, Ehren J, Xia J, Johannsen A, Stuge TB, Gray GM, Lee PP, Khosla C. Siegel M, et al. Among authors: lee pp. Chem Biol. 2006 Jun;13(6):649-58. doi: 10.1016/j.chembiol.2006.04.009. Chem Biol. 2006. PMID: 16793522

10

A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma.

Pullarkat V, Lee PP, Scotland R, Rubio V, Groshen S, Gee C, Lau R, Snively J, Sian S, Woulfe SL, Wolfe RA, Weber JS. Pullarkat V, et al. Among authors: lee pp. Clin Cancer Res. 2003 Apr;9(4):1301-12. Clin Cancer Res. 2003. PMID: 12684398 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

622 results

Search Page